Delavirdine mesylate
Sponsors
National Institute of Allergy and Infectious Diseases (NIAID), Pharmacia and Upjohn, Hoffmann-La Roche, Bristol-Myers Squibb, Agouron Pharmaceuticals
Conditions
HIV Infections
Phase 1
Phase 2
A Comparison of Nelfinavir Plus Saquinavir Plus Delavirdine or 3TC/ZDV Versus Nelfinavir Plus 3TC/ZDV in HIV-Infected Patients
WithdrawnNCT00001094
Updated: 2015-03-09
A Phase II Double-Blind Study of Delavirdine Mesylate ( U-90152 ) in Combination With Zidovudine ( AZT ) and/or Didanosine ( ddI ) Versus AZT and ddI Combination Therapy
CompletedNCT00000803
End: 1997-03-31Target: 471Updated: 2021-11-04
Immunologic and Virologic Consequences of Long-Term Highly Active Antiretroviral Therapy (HAART) in Subjects With Moderately Advanced HIV-1 Disease: A Follow-Up Study to ACTG 315
CompletedNCT00000891
End: 2004-05-31Target: 34Updated: 2021-11-04
The Safety and Effectiveness of Didanosine Plus Stavudine Plus Delavirdine Mesylate Plus MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease Inhibitors
TerminatedNCT00002420
Target: 25Updated: 2008-08-14
Virologic and Immunologic Activity of Continued Lamivudine (3TC) vs Delavirdine (DLV) in Combination With Indinavir (IDV) and Zidovudine (ZDV) or Stavudine (d4T) in 3TC-Experienced Subjects
CompletedNCT00000882
Target: 300Updated: 2013-07-29
A Study of Delavirdine Mesylate in Combination With Other Anti-HIV Drugs in HIV-Infected Children and Babies
CompletedNCT00002210
Target: 24Updated: 2005-06-24
Phase 3
A Phase IIIB Open-Label, Comparative Study to Evaluate Saquinavir Soft Gel Capsule (SGC) Treatment in Combination With Other Antiretrovirals in HIV-1 Infected Antiretroviral-Naive Patients
CompletedNCT00002178
Target: 375Updated: 2005-06-24
A Double-Blind, Randomized, Comparative Study of Delavirdine Mesylate (U-90152S) in Combination With Didanosine (ddI) Versus ddI Alone in HIV-1 Infected Individuals With CD4 Counts of <= 300/mm3
CompletedNCT00002123
Updated: 2005-06-24
A Comparison of Three Anti-HIV Drug Combinations Containing Saquinavir Soft Gelatin Capsules Used in HIV-1 Infected Patients
CompletedNCT00002378
Target: 825Updated: 2005-06-24
A Double-Blind, Randomized, Dose Response Study of Three Doses of Delavirdine Mesylate (U-90152S) in Combination With Zidovudine (ZDV) Versus ZDV Alone in HIV-1 Infected Individuals With CD4 Counts of 200-500mm3
CompletedNCT00002124
Target: 1250Updated: 2005-06-24
Unknown Phase
Safety and Effectiveness of Giving Combinations of Three or Four Anti-HIV Drugs to HIV-Infected Patients
CompletedNCT00002211
Target: 160Updated: 2005-06-24
A Study of Several Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Used Indinavir
CompletedNCT00000892
End: 1999-08-31Target: 300Updated: 2021-11-04
Safety and Effectiveness of 3 Anti-HIV Treatments in Patients Who Have Failed Previous Treatments Containing Nelfinavir
TerminatedNCT00006326
Start: 2000-08-31Target: 60Updated: 2005-06-24
The Safety and Effectiveness of U-90152 in HIV-1 Infected Patients Who Take Zidovudine
CompletedNCT00002312
Updated: 2005-06-24
A Study of Delavirdine Used Together With Other Anti-HIV Drugs in HIV-Infected Patients
CompletedNCT00002401
Target: 160Updated: 2005-06-24
A Study of Two Anti-HIV Drug Combinations in HIV-Infected Patients
CompletedNCT00002400
Target: 45Updated: 2005-06-24
A Study to Find the Best Dosing Schedule for Delavirdine, Zidovudine, and Indinavir in HIV-Positive Patients
CompletedNCT00002236
Target: 32Updated: 2005-06-24